Non-vested share activity for 2016 was as follows:
## Table 0 ##
For the Years Ended
## Table 1 ##
As of the end of 2016, there was $8 million of total unrecognized compensation cost related to non-vested share awards granted under all plans.
That cost is expected to be recognized over a weighted-average period of 1.82 years.
Associate Stock Purchase Plan We established an Associate Stock Purchase Plan (ASPP) in 2001, which qualifies under Section 423 of the Internal Revenue Code.
Each individual employed by us and associates of our U. S.  based subsidiaries, except as provided below, are eligible to participate in the ASPP (Participants).
The following individuals are excluded from participation: (a) persons who, as of the beginning of a purchase period under the Plan, have been continuously employed by us or our domestic subsidiaries for less than two weeks; (b) persons who, as of the beginning of a purchase period, own directly or indirectly, or hold options or rights to acquire under any agreement or Company plan, an aggregate of 5% or more of the total combined voting power or value of all outstanding shares of all classes of Company common stock; and, (c) persons who are customarily employed by us for less than 20 hours per week or for less than five months in any calendar year.
Participants may elect to make contributions from 1% to 20% of compensation to the ASPP, subject to annual limitations determined by the Internal Revenue Service.
Participants may purchase Company common stock at a 15% discount on the last business day of the option period.
The purchase of Company common stock is made through the ASPP on the open market and subsequently reissued to Participants.
The difference between the open market purchase and the Participant’s purchase price is recognized as compensation expense, as such difference is paid by Cerner, in cash.
Share-Based Compensation Cost Our stock option and non-vested share awards qualify for equity classification.
The costs of our ASPP, along with participant contributions, are recorded as a liability until open market purchases are completed.
The amounts recognized in the consolidated statements of operations with respect to stock options, non-vested shares and ASPP are as follows:
## Table 2 ##
EDWARDS LIFESCIENCES CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 12.
EMPLOYEE BENEFIT PLANS (Continued) Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded.
The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value.
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2014, are expected to be paid (in millions):
## Table 3 ##
As of December 31, 2014, expected employer contributions for 2015 are $5.8 million.
Defined Contribution Plans The Company’s employees in the United States and Puerto Rico are eligible to participate in a qualified 401(k) and 1165(e) plan, respectively.
In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan.
Edwards Lifesciences matches the first 3% of the participant’s annual eligible compensation contributed to the plan on a dollar-for-dollar basis.
Edwards Lifesciences matches the next 2% of the participant’s annual eligible compensation to the plan on a 50% basis.
In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan.
Edwards Lifesciences matches the first 4% of participant’s annual eligible compensation contributed to the plan on a 50% basis.
The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee.
Matching contributions relating to Edwards Lifesciences employees were $12.8 million, $12.0 million, and $10.8 million in 2014, 2013, and 2012, respectively.
The Company also has nonqualified deferred compensation plans for a select group of employees.
The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant.
The amount accrued under these nonqualified plans was $28.7 million and $25.9 million at December 31, 2014 and 2013, respectively.13.
COMMON STOCK Treasury Stock In May 2013, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $750.0 million of the Company’s common stock from time to time until December 31, 2016.
In July 2014, the Board of Directors approved a new stock repurchase program providing for an additional $750.0 million of repurchases without a specified end date.
Stock repurchased under these programs will be used to offset obligations under the Company’s employee stock option programs and reduce the total shares outstanding.
During 2014, 2013, and 2012, the Company repurchased 4.4 million, 6.8 million, and 4.0 million shares, respectively, at an aggregate cost of $300.9 million, $497.0 million, and $353.2 million, respectively, including shares purchased under the accelerated share repurchase (‘‘ASR’’) agreements described below and shares
Net operating revenues in the United States were $19.8 billion in 2014, or 43 percent of the Company’s consolidated net operating revenues.
We expect existing domestic cash, cash equivalents, short-term investments, marketable securities, cash flows from operations and the issuance of debt to continue to be sufficient to fund our domestic operating activities and cash commitments for investing and financing activities.
In addition, we expect existing foreign cash, cash equivalents, short-term investments, marketable securities and cash flows from operations to continue to be sufficient to fund our foreign operating activities and cash commitments for investing activities.
In the future, should we require more capital to fund significant discretionary activities in the United States than is generated by our domestic operations or is available through the issuance of debt, we could elect to repatriate future periods’ earnings from foreign jurisdictions.
This alternative could result in a higher effective tax rate.
While the likelihood is remote, the Company could also elect to repatriate earnings from foreign jurisdictions that have previously been considered to be indefinitely reinvested.
Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to additional U. S.  income taxes (net of an adjustment for foreign tax credits) and withholding taxes payable to various foreign jurisdictions, where applicable.
This alternative could also result in a higher effective tax rate in the period in which such a determination is made to repatriate prior period foreign earnings.
Refer to Note 14 of Notes to Consolidated Financial Statements for further information related to our income taxes and undistributed earnings of the Company’s foreign subsidiaries.
Based on all the aforementioned factors, the Company believes its current liquidity position is strong, and we will continue to meet all of our financial obligations and other anticipated cash outflows for the foreseeable future.
These obligations and anticipated cash outflows include, but are not limited to, regular quarterly dividends, debt maturities, capital expenditures, share repurchases and obligations included under the heading “Off-Balance Sheet Arrangements and Aggregate Contractual Obligations” below.
Cash Flows from Operating Activities Net cash provided by operating activities for the years ended December 31, 2014, 2013 and 2012 was $10,615 million, $10,542 million and $10,645 million, respectively.
Cash flows from operating activities increased $73 million, or 1 percent, in 2014 compared to 2013.
This increase primarily reflects the incremental pension contributions that were made in the first quarter of 2013 compared to 2014 as well as efficient management of working capital.
The increase was partially offset by an unfavorable impact of currency exchange rates during 2014.
Cash flows from operating activities decreased $103 million, or 1 percent, in 2013 compared to 2012.
This decrease primarily reflects the impact of foreign currency fluctuations, an increase in tax payments and the effect of the deconsolidation of our Philippine and Brazilian bottling operations during 2013, partially offset by lower pension funding in 2013 compared to 2012.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the deconsolidation of these bottling operations.
Refer to the heading “Operations Review — Net Operating Revenues” above for additional information on the impact of foreign currency fluctuations.
Refer to Note 13 and Note 14 of Notes to Consolidated Financial Statements for additional information on the pension funding and tax payments.
Cash Flows from Investing Activities Our cash flows provided by (used in) investing activities are summarized as follows (in millions):
## Table 4 ##
The gains, net of noncontrolling interests and excluding gains from the sale of certain available-for-sale securities, of $16.1 million in 2010 were due to the following: ?
Net gains of $7.8 million from our managed funds primarily related to increased valuations.  ?
Net gains of $4.7 million from our debt funds primarily related to gains from distributions and our share of debt fund operating income.
Foreign Exchange Fees Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients.
Foreign exchange fees were $43.9 million in 2011, compared to $36.2 million and $30.7 million in 2010 and 2009, respectively.
The increases in foreign exchange fees in 2011 and 2010 were primarily due to improving business conditions for our clients and increased volatility in foreign markets, which has resulted in higher commissioned notional volumes.
Commissioned notional volumes were $9.3 billion in 2011, compared to $6.7 billion and $5.0 billion in 2010 and 2009, respectively.
Gains (Losses) on Derivative Instruments, Net A summary of gains (losses) on derivative instruments, net, for 2011, 2010 and 2009 is as follows:

<table><tr><td>(In thousands, except per share data)</td><td>Number of Shares</td><td>Weighted-AverageGrant Date Fair Value</td></tr><tr><td>Outstanding at beginning of year</td><td>557</td><td>$59.42</td></tr><tr><td>Granted</td><td>58</td><td>57.22</td></tr><tr><td>Vested</td><td>-216</td><td>53.74</td></tr><tr><td>Forfeited</td><td>-45</td><td>70.37</td></tr><tr><td>Outstanding at end of year</td><td>354</td><td>$61.12</td></tr></table>
<table><tr><td></td><td colspan="3">For the Years Ended</td></tr><tr><td>(In thousands, except for grant date fair values)</td><td>2016</td><td>2015</td><td>2014</td></tr><tr><td>Weighted average grant date fair values for shares granted during the year</td><td>$57.22</td><td>$68.57</td><td>$55.27</td></tr><tr><td>Total fair value of shares vested during the year</td><td>$12,221</td><td>$13,730</td><td>$11,294</td></tr></table>
<table><tr><td></td><td colspan="3">For the Years Ended</td></tr><tr><td>(In thousands)</td><td>2016</td><td>2015</td><td>2014</td></tr><tr><td>Stock option and non-vested share compensation expense</td><td>$74,536</td><td>$70,121</td><td>$59,292</td></tr><tr><td>Associate stock purchase plan expense</td><td>6,537</td><td>5,393</td><td>4,603</td></tr><tr><td>Amounts capitalized in software development costs, net of amortization</td><td>-482</td><td>-588</td><td>-930</td></tr><tr><td>Amounts charged against earnings, before income tax benefit</td><td>$80,591</td><td>$74,926</td><td>$62,965</td></tr><tr><td>Amount of related income tax benefit recognized in earnings</td><td>$24,749</td><td>$23,435</td><td>$22,101</td></tr></table>
<table><tr><td>2015</td><td>$3.7</td></tr><tr><td>2016</td><td>5.5</td></tr><tr><td>2017</td><td>4.2</td></tr><tr><td>2018</td><td>4.2</td></tr><tr><td>2019</td><td>4.1</td></tr><tr><td>2020-2024</td><td>32.3</td></tr></table>
<table><tr><td>Year Ended December 31,</td><td>2014</td><td>2013</td><td>2012</td></tr><tr><td>Purchases of investments</td><td>$-17,800</td><td>$-14,782</td><td>$-14,824</td></tr><tr><td>Proceeds from disposals of investments</td><td>12,986</td><td>12,791</td><td>7,791</td></tr><tr><td>Acquisitions of businesses, equity method investments and nonmarketable securities</td><td>-389</td><td>-353</td><td>-1,486</td></tr><tr><td>Proceeds from disposals of businesses, equity method investments and nonmarketable securities</td><td>148</td><td>872</td><td>20</td></tr><tr><td>Purchases of property, plant and equipment</td><td>-2,406</td><td>-2,550</td><td>-2,780</td></tr><tr><td>Proceeds from disposals of property, plant and equipment</td><td>223</td><td>111</td><td>143</td></tr><tr><td>Other investing activities</td><td>-268</td><td>-303</td><td>-268</td></tr><tr><td>Net cash provided by (used in) investing activities</td><td>$-7,506</td><td>$-4,214</td><td>$-11,404</td></tr></table>

Question: what was the average purchase price of company repurchased shares in 2013?
Answer: 73.08824